111 related articles for article (PubMed ID: 18225395)
1. Carcinogenesis and the hypothesis of phylogenetic reversion.
Blanca A; Requena MJ; Carrasco JC
Anal Quant Cytol Histol; 2007 Dec; 29(6):379-80. PubMed ID: 18225395
[No Abstract] [Full Text] [Related]
2. Carcinogenesis and the hypothesis of phylogenetic reversion.
Bartels PH; Ranger-Moore J; Alberts D; Hess L; Scarpelli M; Montironi R
Anal Quant Cytol Histol; 2006 Oct; 28(5):243-52. PubMed ID: 17067006
[TBL] [Abstract][Full Text] [Related]
3. Silencing of bidirectional promoters by DNA methylation in tumorigenesis.
Shu J; Jelinek J; Chang H; Shen L; Qin T; Chung W; Oki Y; Issa JP
Cancer Res; 2006 May; 66(10):5077-84. PubMed ID: 16707430
[TBL] [Abstract][Full Text] [Related]
4. WT1 CpG islands methylation in human lung cancer: a pilot study.
Bruno P; Gentile G; Mancini R; De Vitis C; Esposito MC; Scozzi D; Mastrangelo M; Ricci A; Mohsen I; Ciliberto G; Simmaco M; Mariotta S
Biochem Biophys Res Commun; 2012 Sep; 426(3):306-9. PubMed ID: 22925896
[TBL] [Abstract][Full Text] [Related]
5. Epigenetics in carcinogenesis and cancer prevention.
Jones PA
Ann N Y Acad Sci; 2003 Mar; 983():213-9. PubMed ID: 12724226
[TBL] [Abstract][Full Text] [Related]
6. [Promoter hypermethylation and CpG island methylator phenotype in colorectal carcinogenesis].
Matsubara N
Gan To Kagaku Ryoho; 2010 Sep; 37(9):1659-64. PubMed ID: 20841928
[TBL] [Abstract][Full Text] [Related]
7. Dormant hypermethylated tumour suppressor genes: questions and answers.
Esteller M
J Pathol; 2005 Jan; 205(2):172-80. PubMed ID: 15643671
[TBL] [Abstract][Full Text] [Related]
8. The role of epigenetics in carcinogenesis.
Lichter P
Int J Cancer; 2008 Jul; 123(1):ix. PubMed ID: 18435465
[No Abstract] [Full Text] [Related]
9. [DNA methylation as an etiologic factor in carcinogenesis].
Zaletaev DV; Nemtsova MV; Bochkov NP
Vestn Ross Akad Med Nauk; 2002; (4):6-11. PubMed ID: 12046338
[TBL] [Abstract][Full Text] [Related]
10. MPP3 inactivation by promoter CpG islands hypermethylation in colorectal carcinogenesis.
Feng X; Chen K; Ye S; Wang H; Wei G; Tan W; Cheng S; Zhang Y; Liu S; Zhou Y
Cancer Biomark; 2012; 11(2-3):99-106. PubMed ID: 23011156
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation and epigenetic mechanisms of carcinogenesis.
Baylin S
Dev Biol (Basel); 2001; 106():85-7; discussion 143-60. PubMed ID: 11761271
[No Abstract] [Full Text] [Related]
12. CpG island promoter hypermethylation of Ras association domain family 1A gene contributes to gastric carcinogenesis.
Joo MK; Kim KH; Park JJ; Yoo HS; Choe J; Kim HJ; Lee BJ; Kim JS; Bak YT
Mol Med Rep; 2015 Apr; 11(4):3039-46. PubMed ID: 25483734
[TBL] [Abstract][Full Text] [Related]
13. Elements for an integrated approach to carcinogenesis.
Capp JP
Bioessays; 2006 Feb; 28(2):228. PubMed ID: 16435304
[No Abstract] [Full Text] [Related]
14. Epigenetics: surveillance team against cancer.
Klein G
Nature; 2005 Mar; 434(7030):150. PubMed ID: 15758980
[No Abstract] [Full Text] [Related]
15. Early S phase DNA replication: a search for targets of carcinogenesis.
Kaufman DG; Cordeiro-Stone M; Brylawski BP; Cohen SM; Chastain PD
Adv Enzyme Regul; 2007; 47():127-38. PubMed ID: 17337290
[No Abstract] [Full Text] [Related]
16. Back to the beginning: The initiation of cancer.
Cobaleda C; Sánchez-García I
Bioessays; 2013 May; 35(5):413. PubMed ID: 23553938
[No Abstract] [Full Text] [Related]
17. Normal Somatic Mutations in Cancer Transformation.
Wijewardhane N; Dressler L; Ciccarelli FD
Cancer Cell; 2021 Feb; 39(2):125-129. PubMed ID: 33220180
[TBL] [Abstract][Full Text] [Related]
18. [Understanding carcinogenesis].
Laiho M
Duodecim; 2002; 118(17):1751-8. PubMed ID: 12370981
[No Abstract] [Full Text] [Related]
19. Apoptosis in carcinogenesis and cancer therapy.
Chen GG; Lai PB
Curr Cancer Drug Targets; 2010 Sep; 10(6):554. PubMed ID: 21198442
[No Abstract] [Full Text] [Related]
20. Cancer: an epigenetic landscape.
Dhanasekaran K; Arif M; Kundu TK
Subcell Biochem; 2013; 61():399-417. PubMed ID: 23150260
[No Abstract] [Full Text] [Related]
[Next] [New Search]
